QLG — Integrated Continuous Glucose Monitoring System, Factory Calibrated, Not For Use With Automated Insulin Delivery Systems Class II

FDA Device Classification

Classification Details

Product Code
QLG
Device Class
Class II
Regulation Number
862.1355
Submission Type
Review Panel
CH
Medical Specialty
Clinical Chemistry
Implant
No

Definition

An integrated continuous glucose monitoring system for replacement of finger stick blood glucose testing for diabetes treatment decisions in persons with diabetes, unless otherwise indicated. The system automatically measures glucose in bodily fluids continuously or frequently for a specified period of time. The system is also designed to reliably and securely transmit glucose measurement data to digitally connected devices and are intended to be used alone or in conjunction with these digitally connected devices where the user manually controls actions for therapy decisions. The system is not intended to be used with automated insulin dosing (AID) systems.

Recent 510(k) Clearances

K-NumberApplicantDevice NameDate
K222280bigfoot biomedicalBigfoot Unity® Diabetes Management SystemMarch 1, 2023
K223537abbott diabetes careFreeStyle Libre 2 System, FreeStyle Libre 3 SystemFebruary 21, 2023
K212132abbott diabetes careFreeStyle Libre 3 Continuous Glucose Monitoring SystemMay 26, 2022
K213996abbott diabetes careFreeStyle Libre 3 Continuous Glucose Monitoring SystemMay 26, 2022
K210943abbott diabetes careFreeStyle Libre 2 Flash Glucose Monitoring System (with FreeStyle Libre 2 App)November 22, 2021
K211102abbott diabetes careFreeStyle Libre 2 Flash Glucose Monitoring SystemAugust 11, 2021
K201761abbott diabetes careFreeStyle Libre 2 Flash Glucose Monitoring System (with FreeStyle Libre 2 App)July 30, 2021
K202145bigfoot biomedicalBigfoot Unity Diabetes Management SystemMay 7, 2021
K193371abbott diabetes careFreeStyle Libre 2 Flash Glucose Monitoring SystemJune 12, 2020